home

MRTX.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
MRTX
US
Mirati Ther

Market global news for MRTX (US) Mirati Ther

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
BMS leans on long-term growth drivers to dodge IRA impacts
fiercepharma - 20:45 Thu 25 - MRTX - link story
Bristol Myers posts quarterly loss, revenue rises 5%
whbl - 18:15 Thu 25 - MRTX - link story
Bristol Myers posts quarterly loss, revenue rises 5%
saltwire - 14:00 Thu 25 - MRTX - link story
Bristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed Overview
yahoo - 14:00 Thu 25 - MRTX - link story
UPDATE 2-Bristol Myers posts quarterly loss, revenue rises 5%
biztoc - 13:45 Thu 25 - MRTX - link story
Bristol Myers Posts Quarterly Loss, Revenue Rises 5%
usnews - 13:00 Thu 25 - MRTX - link story
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
marketscreener - 11:15 Thu 25 - MRTX - link story
Critical Analysis: GH Research (NASDAQ:GHRS) and ORIC Pharmaceuticals (NASDAQ:ORIC)
tickerreport - 08:45 Wed 24 - MRTX - link story
Contrasting GH Research (NASDAQ:GHRS) & ORIC Pharmaceuticals (NASDAQ:ORIC)
dailypolitical - 08:45 Wed 24 - MRTX - link story
Global Colorectal Cancer Pipeline Insights Report For 2024: An In-Depth Analysis Of Clinical And Nonclinical Developments
menafn - 14:15 Tue 23 - MRTX - link story
Global Colorectal Cancer Pipeline Insights Report for 2024:
globenewswire - 11:45 Tue 23 - MRTX - link story
Phase 3 Trials Reveal New Standards of Care for NSCLC
cancertherapyadvisor - 10:30 Tue 16 - MRTX - link story
KRAZATI (adagrasib) in Combination with Cetuximab Demonstrates Clinically Meaningful Activity as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
eagletribune - 18:45 Mon 8 - MRTX - link story
AACR: Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer
newswise - 16:45 Mon 8 - MRTX - link story
AACR: Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer
newswise - 16:45 Mon 8 - MRTX - link story
AACR: Combo Treatment Effective Against Metastatic Colorectal Cancer
miragenews - 16:00 Mon 8 - MRTX - link story
KRAZATI (adagrasib) in Combination with Cetuximab Demonstrates Clinically Meaningful Activity as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
marketscreener - 16:00 Mon 8 - MRTX - link story
Week In Review: Seattle-Suzhou ADC Biotech ProfoundBio Acquired By Genmab For $1.8 Billion
seekingalpha - 11:30 Sun 7 - MRTX - link story
Addressing Ongoing Diversity Gaps in Oncology Clinical Trials
pharmacytimes - 18:00 Fri 5 - MRTX - link story
UK billionaire Joe Lewis, 87, avoids jail in insider trading case
biznews - 13:45 Fri 5 - MRTX - link story
Tottenham mogul Lewis spared prison for insider trading
tribune pk - 13:30 Fri 5 - MRTX - link story
UK billionaire Joe Lewis avoids jail for insider trading
afr - 23:15 Thu 4 - MRTX - link story
Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC
pharmacytimes - 23:15 Thu 4 - MRTX - link story
British billionaire Joe Lewis fined $5 million by US judge for insider trading
swissinfo ch - 22:45 Thu 4 - MRTX - link story
UK Billionaire Joe Lewis Avoids Prison With 3-Year Probation
bnnbloomberg ca - 22:45 Thu 4 - MRTX - link story
UK billionaire Joe Lewis avoids jail, fined US$5 million by US judge for insider trading
scmp - 22:30 Thu 4 - MRTX - link story
British billionaire Joe Lewis fined $5 million by U.S. judge for insider trading
cnbc - 22:15 Thu 4 - MRTX - link story
Tottenham mogul Lewis spared prison for insider trading
france24 - 22:00 Thu 4 - MRTX - link story
British billionaire Joe Lewis fined $5 million by US judge for insider trading
devdiscourse - 21:45 Thu 4 - MRTX - link story
Merck puts KRAS cancer drug competitor to the test
biopharmadive - 19:15 Thu 4 - MRTX - link story
Multibillionaire Joe Lewis to face US sentencing for insider trading
oann - 17:45 Thu 4 - MRTX - link story
British multibillionaire Joe Lewis to face sentencing in U.S. court for insider trading
theglobeandmail - 16:45 Thu 4 - MRTX - link story
Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
sandiegouniontribune - 23:15 Wed 3 - MRTX - link story
87-year-old billionaire Joe Lewis will be punished enough with a less than 18-month sentence for insider trading, U.S. prosecutors say
fortune - 10:45 Tue 2 - MRTX - link story
UK Billionaire Lewis Deserves Leniency for Insider Tips, US Says
bnnbloomberg ca - 05:45 Tue 2 - MRTX - link story
One Good, One Bad News For Bristol Myers Squibb's Marketed Drugs: Details - Bristol-Myers Squibb (NYSE:BMY)
benzinga - 14:15 Mon 1 - MRTX - link story
Bristol Myers says KRAS drug succeeds in key trial
biopharmadive - 01:15 Sat 30 - MRTX - link story
Rx Rundown: Merck, Novo Nordisk, Viking Therapeutics and more
mmm-online - 15:00 Fri 29 - MRTX - link story
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
eagletribune - 14:15 Thu 28 - MRTX - link story
Bristol Myers Squibb cuts hundreds of Mirati staffers months after closing $5.8B buyout
fiercepharma - 23:15 Tue 26 - MRTX - link story
Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team
lelezard - 21:45 Tue 26 - MRTX - link story